Ben Philpot, PhD
February 15, 2026
We develop therapeutics (gene therapies, ASO, small molecules, CRISPR, etc.) to treat single gene neurodevelopmental disorders such as Angelman syndrome, Pitt-Hopkins syndrome, and Dup15q syndrome. We also work to treat a vision disorder–IMPG2-mediated retinitis pigmentosa.